US Patent 11933856 Cross spectral impedance assessment for cell qualification
Patent 11933856 was granted and assigned to Dynexus Technology, Inc. on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11933856 Cross spectral impedance assessment for cell qualification
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.